2021

Regular papers

  1. Stabilization of an 211At-labelled antibody with sodium ascorbate
    Shino Manabe, Hiroki Takashima, Kazunobu Ohnuki, Yoshikatsu Koga, Ryo Tsumura, Nozomi Iwata, Yang Wang, Takuya Yokokita, Yukiko Komori, Sachiko Usuda, Daiki Mori, Hiromitsu Haba, Hirofumi Fujii, Masahiro Yasunaga, Yasuhiro Matsumura
    ACS Omega, in press. DOI:10.1021/acsomega.1c00684
  2. Antitumor effect of an 211At-labeled anti-tissue factor antibody protected by sodium ascorbate in gastric cancer xenograft models
    Hiroki Takashima, Yoshikatsu Koga, Shino Manabe, Kazunobu Onuki, Ryo Tsumura, Takahiro Anzai, Nozomi Iwata, Yan Wang, Takuya Yokokita, Yukiko Komori, Daiki Mori, Hiromitsu Haba, Hirofumi Fujii, Yasuhiro Matsumura, Masahiro Yasunaga,
    Cancer Sci. 112(5), 1975–1986 (2021) DOI:10.1111/cas.14857
  3. Quantification of serum C-mannosyl tryptophan by novel assay to evaluate renal function and vascular complications in patients with type 2 diabetes
    Shuhei Morita, Yoko Inai, Shiho Minakata, Shohei Kishimoto, Shino Manabe, Naoyuki Iwahashi, Kazuhiko Ino, Yukishige Ito, Takashi Akamizu, Yoshito Ihara
    Sci. Rep. 11, 1946 (2021) DOI:10.1038/s41598-021-81479-y
  4. Antitumor effect of humanized anti-tissue factor antibody-drug conjugate in peritoneal disseminated pancreatic cancer model
    Ryo Tsumura, Takahiro Anzai, Shino Manabe, Hiroki Takashima, Yoshikatsu Koga, Masashiro Yasunaga, Yasuhiro Matsumura
    Oncol. Rep. 45(1), 329-336 (2021) DOI:10.3892/or.2020.7850
  5. Stereoselective 1,4-Addition of Primary Alcohols to γ-Alkoxy-α,β-unsaturated Esters
    Saki Inatomi, Yuta Takayanagi, Kento Watanabe, Akinori Toita, Hiroyuki Yamakoshi, Seiichi Nakamura
    Synthesis 53(01), 161–174 (2021) DOI:10.1055/s-0040-1707274

Reviews

  1. Antibody glycoengineering and homogeneous antibody-drug conjugate preparation
    S. Manabe, Y. Yamaguchi
    Chem. Rec. in press. DOI:10.1002/tcr.202100054
  2. Recent development of stereoselective glycosylation reactions
    Shino Manabe
    Heterocycles, 102(2) 177-201 (2021) DOI:10.3987/REV-20-933

Proceedings

  1. Development of radioimmunotherapy with astatine-211-counjugated antibodies Hiroki Takashima, Yoshikatsu Koga, K. Onuki, Shino Manabe, Ryo Tsumura T. Anzai, N. Iwata, Masahiro Yasunaga, W. Yang, T. Yokokita, Yukiko Komori, Daiki Mori, Hitomitsu Haba, Hirofumi Fujii, Yasuhiro Matsumura
    RIKEN Accel. Prog. Rep. in press.

Books

  1. C-Mannosyl tryptophan: from chemistry to biology
    Yoshito Ihara, Shino Manabe, Yoko Inai, Yukishige Ito, in “Comprehensive Glycoscience, IV Second Edition“ Johannis P. Karmerling, Gert. J. Boons, Yuan Chan Lee, Akemi Suzuki, Naoyuki Taniguchi, A. G. J. Voragen eds.
    Elsevier, in press.

2020年

Regular papers

  1. Monomeric C-mannosyl tryptophan is a degradation product of autophagy in cultured cells
    Shiho Minakata, Yoko Inai, Shino Manabe, Kazuchika Nishitsuji, Yukishige Ito, Yoshito Ihara
    Glycoconj. J. 37(5), 635-645 (2020) DOI:10.1007/s10719-020-09938-8
  2. C-Mannosyl tryptophan increases in the plasma of ovarian cancer
    Naoyuki Iwahashi, Yoko Inai, Shiho Minakata, Sho Sakurai, Shino Manabe, Yukishige Ito, Kazuhiko Ino, Yoshito Ihara
    Oncol. Lett. 19(1), 908-919 (2020) DOI:10.3892/ol.2019.11161
  3. Quantitative Drug Dynamics Visualized by Alkyne-Tagged Plasmonic-Enhanced Raman microscopy
    Kota Koike, Kazuki Bando, Jun Ando, Hiroyuki Yamakoshi, Naoki Terayama, Kosuke Dodo, Nicholas Isaac Smith, Mikiko Sodeoka, and Katsumasa Fujita,
    ACS Nano 14(11), 15032–15041 (2020) DOI:10.1021/acsnano.0c05010
  4. Kir6.1 heterozygous mice exhibit aberrant amygdala-dependent cued fear memory
    Ryo Inagaki†, Shigeki Moriguchi†, and Kohji Fukunaga, (†Contributd equally to this work)
    Mol Neurobiol 57, 1622-1635 (2020) DOI:10.1007/s12035-019-01840-1
  5. Memantine improves depressive-like behaviors via Kir6.1 channel inhibition in olfactory bulbectomized mice
    Shigeki Moriguchi, Ryo Inagaki, Hirotsugu Shimojo, Yoshihiko Sugimura, and Kohji Fukunaga
    Neuroscience 442, 264-273 (2020) DOI:10.1016/j.neuroscience.2020.06.002
  6. Nicotine rescues depressive-like behaviors via α7-type nicotinic acetylcholine receptor activation in CaMKIV null mice
    Shigeki Moriguchi, Ryo Inagaki, Lusha Yi, Mikako Shibata, Hiroyuki Sakagami, and Kohji Fukunaga
    Mol Neurobiol 57, 4929-4940 (2020) DOI:10.1007/s12035-020-02077-z
  7. Scabronine G methyl ester improves memory-related behavior and enhances hippocampal cell proliferation and long-term potentiation via the BDNF-CREB pathway in olfactory bulbectomized mice
    Osamu Nakagawasai, Lin Jia-Rong, Takayo Odaira, Kohei Takahashi, Wataru Nemoto, Shigeki Moriguchi, Yasushi Yabuki, Yu Kobayakawa, Kohji Fukunaga, Masahisa Nakada, and Koichi Tan-No
    Front Pharmacol 11, 583291 (2020) DOI:10.3389/fphar.2020.583291

Reviews

  1. Glycan-conjugated homogeneous antibody-drug conjugate synthesis
    Shino Manabe
    Translate. Regulat. Sci. 2(3), 84–89 (2020) DOI:10.33611/trs.2020_012

2019年

BOOK

  1. Recent Progress in Linker Technology for Antibody-drug Conjugates: Methods for Connection and Release
    Shino Manabe
    Cancer Drug Delivery Systems based on the Tumor Microenvironment. eds. by Yasuhiro Matsumura and David Tarin, Springer, pp. 93-123 (2019)
  2. Preclinical Studies of ADC Therapy for Solid Tumors
    Yoshikatsu Koga, Ryo Tsumura, Shino Manabe, Yasuhiro Matsumura
    Cancer Drug Delivery Systems based on the Tumor Microenvironment. eds. by Yasuhiro Matsumura and David Tarin Springer, pp. 125-154 (2019)
  3. CAST Therapy
    Masahiro Yasunaga, Shino Manabe, Yasuhiro Matsumura
    Cancer Drug Delivery Systems based on the Tumor Microenvironment. eds. by Yasuhiro Matsumura and David Tarin Springer, pp. 269-288 (2019)

REVIEWS

  1. Tips for DDS; Normal and Reverse phase DDS (J)
    Shino Manabe
    Drug Delivery Syst. 35, 147-149 (2020)
  2. Importance of Linker Design in ADC Development (J)
    Shino Manabe and Yoshiki Yamaguchi
    Medical Review, 17, 11-15 (2019)
  3. Antibody-drug conjugate preparation though Glycan Remodeling (J)
    Shino Manabe and Yoshiki Yamaguchi
    Fine Chemical, 48, 51-59 (2019)

REGULAR ARTICLES

  1. Aberrant amygdala-dependent cued fear memory in Na+/Ca2+  exchanger 1 heterozygous mice
    Shigeki Moriguchi, Satomi Kita, Ryo Inagaki, Yasushi Yabuki, Yuzuru Sasaki, Shun Ishikawa, Hiroyuki Sakagami, Takahiro Iwamoto and Kohji Fukunaga
    Mol. Neurobiol. 56, 4381-4394 (2019)
  2. Synthesis of Propargylic Ethers by Gold-Mediated Reaction of Terminal Alkynes with Acetals
    Miyu Furuta, Kyoko Sugiyama, Minami Yamaguchi, Hirofumi Ueda, Hidetoshi Tokuyama
    Chem. Pharm. Bull., 67, 872-876 (2019)
  3. Selenoprotein P; P for Plasma, Prognosis, Prophylaxis, and More
    Ryouhei Tsutsumi and Yoshiro Saito
    Biological and Pharmaceutical Bulletin43, 366-374(2020)
  4. Protease-activated receptor 2 exacerbates cisplatin-induced nephrotoxicity.
    Mari Watanabe, Yuji Oe, Emiko Sato, Akiyo Sekimoto, Hiroshi Sato, Sadayoshi Ito, and Nobuyuki
    Takahashi
    American Journal of Physiology Renal Physiology, 316(4), F654-F659, (2019)
  5. Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL/lpr mice treated
    with lipopolysaccharide.
    Kenta Imaruoka, Yuji Oe, Tomofumi Fushima, Emiko Sato, Akiyo Sekimoto, Hiroshi Sato, Junichi
    Sugawara, Sadayoshi Ito, Nobuyuki Takahashi
    Biochemical and Biophysical Research Communications, 510(4), 587-593, (2019)
  6. Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and
    podocyte injury.
    Yuji Oe, Tomofumi Fushima, Emiko Sato, Akiyo Sekimoto, Kiyomi Kisu, Hiroshi Sato, Junichi
    Sugawara, Sadayoshi Ito, Nobuyuki Takahashi
    Scientific Reports, 9, 2986, (2019)
  7. Tadalafil alleviates preeclampsia and fetal growth restriction in RUPP model of preeclampsia in mice.
    Akiyo Sekimoto, KayoTanaka , Yamato Hashizume, Emiko Sato, Tomoaki Ikeda, Nobuyuki Takahashi
    Biochemical and Biophysical Research Communications, 521(3), 769-774, (2020)
  8. Glomerular Injury Is Exacerbated in Lupus-Prone MRL/lpr Mice Treated with a Protease-Activated
    Receptor 2 Antagonist.
    Rina Itto, Yuji Oe, Kenta Imaruoka, Emiko Sato, Akiyo Sekimoto, Shu Yamakage, Satoshi Kumakura,
    Hiroshi Sato, Sadayoshi Ito, Nobuyuki Takahashi
    Tohoku Journal of Experimental Medicine, 249(2), 127-133, (2019)